SALT LAKE CITY, Jan. 29, 2004 (PRIMEZONE) -- This newly released product by Advanced Healthcare Technologies, Inc. (OTCBB:AVHC) is specifically designed to support prostate health and improve male libido. Male Virility is a new proprietary blend formulated to naturally balance hormones and improve overall vitality in men. According to Associated Press, one of the most comprehensive surveys in the United States found 31% of men have a problem with sexual dysfunction. Additional studies suggest that 50% of American men over the age of forty suffer from poor sexual health.
NutraTek will market Male Virility through healthcare professionals. Initial customer response puts it on track to be one of the Company's top selling products. Private label discussions are underway to retail this product through established Multilevel Marketing companies. The proprietary blend is believed to be more effective than and unique from other dietary supplements on the market. Male Virility is designed to help improve the function of overall male vitality rather than just erectile dysfunction (ED).
Male Virility works by providing the precursors essential for health, including hormone production and prostate health. Specialized natural ingredients may provide support for healthy testosterone production. Specific components of this formula are designed to naturally activate over 100 enzymes in the body, making it a good overall support to men's health.
Chief Science Officer, Joel Rockwood states, "We are very excited about the potential of the Male Virility product. Initial customer reaction tells us this will help many people and should be a blockbuster product. Our research team is consistently seeking out products that improve people's quality of life."
About Advanced Healthcare Technologies-NutraTek:
Advanced Healthcare Technologies is a biotechnology company that engages in the development of products and services in the health and wellness industry.
Company Mission: "NutraTek is in the business of improving health, lifestyle and beauty through long-term and repeat sales."
Company motto: "Achieve Your Genetic Potential."
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
HTML: http://newsroom.eworldwire.com/wr/012904/2111.htm PDF: http://newsroom.eworldwire.com/pdf/012904/2111.pdf ONLINE NEWSROOM: http://newsroom.eworldwire.com/2027.htm LOGO: http://newsroom.eworldwire.com/2027.htm